Research & Innovation
Publications

Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.

#2022

#Cancers

PMU Authors
Romana Wass, Brane Grambozov, Felix Sedlmayer, Michael Studnicka, Franz Zehentmayr

All Authors
Romana Wass, Maximilian Hochmair, Bernhard Kaiser, Brane Grambozov, Petra Feurstein, Gertraud Weiß, Raphaela Moosbrugger, Felix Sedlmayer, Bernd Lamprecht, Michael Studnicka, Franz Zehentmayr

Journal association
Cancers

Abstract

Keywords

SURVIVAL, RADIOTHERAPY, CONSOLIDATION, CHEMORADIATION, PHASE-III, CELL LUNG-CANCER, CONCURRENT, INHIBITOR-RELATED PNEUMONITIS, REAL-WORLD DATA, RTOG 0617

Latest Publication

#2025

#Review article

Kathrin Julia Pann, Verena-Katrin Buchner, Roland Eßl-Maurer, Tobias Bacher, Manela Glarcher, Andre Ewers International competencies of nurses with advanced practice in anesthesia nursing

#2025

#Original Article

Kathrin Julia Pann, Verena-Katrin Buchner, Roland Essl-Maurer, Tobias Bacher, Manela Glarcher, Andre Ewers International competencies of nurses with advanced practice in anesthesia nursing, Advanced practice nursing; Advanced practice registered nurses; Anesthesia nursing; Clinical competence; Literature review; Nurse anesthetists; Scope of practice;

#2025

#Original Article

Emanuele Bernardinelli, Rapolas Jamontas, Arnoldas Matulevičius, Florian Huber, Houssein Nasser, Sophie Klaus, Haixia Zhu, Jiangang Gao, Silvia Dossena Inhibitors of the ubiquitin‑proteasome system rescue cellular levels and ion transport function of pathogenic pendrin (SLC26A4) protein variants, Humans; Animals; MICE; HEK293 Cells; MUTATION; Proteasome Endopeptidase Complex/metabolism; Sulfate Transporters/metabolism; Ion Transport/drug effects; Proteasome Inhibitors/pharmacology; Ubiquitin/metabolism; Hearing Loss, Sensorineural/metabolism; Goiter, Nodular/metabolism; Proteolysis/drug effects;

Back to Overview

Paracelsus Medical University (PMU) Research & Innovation Publications

Durvalumab after Sequential High Dose...